NCT00171535View on ClinicalTrials.gov

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Hypertension
Interventions
DRUG

valsartan/amlodipine

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171535 - Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension | Biotech Hunter | Biotech Hunter